Discontinuation of anticoagulant therapy for a month in a patient with HeartMate III continuous-flow left ventricular assist device without thromboembolic events

The recommended anticoagulation regimen for continuous-flow left ventricular assist device (LVAD) systems is warfarin and aspirin with a targeted international normalized ratio (INR) of 2.0–3.0. Our patient is a 58-year-old male who underwent surgical HeartMate III continuous-flow LVAD implantation...

Descripción completa

Detalles Bibliográficos
Autores principales: Elasfar, Abdelfatah, Jalali, Kafaf, Hussein, Mohamed, AlHarbi, Ibraheem, Amoudi, Osama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035384/
https://www.ncbi.nlm.nih.gov/pubmed/29989026
http://dx.doi.org/10.1016/j.jsha.2017.12.002
_version_ 1783338041087098880
author Elasfar, Abdelfatah
Jalali, Kafaf
Hussein, Mohamed
AlHarbi, Ibraheem
Amoudi, Osama
author_facet Elasfar, Abdelfatah
Jalali, Kafaf
Hussein, Mohamed
AlHarbi, Ibraheem
Amoudi, Osama
author_sort Elasfar, Abdelfatah
collection PubMed
description The recommended anticoagulation regimen for continuous-flow left ventricular assist device (LVAD) systems is warfarin and aspirin with a targeted international normalized ratio (INR) of 2.0–3.0. Our patient is a 58-year-old male who underwent surgical HeartMate III continuous-flow LVAD implantation 3 months ago outside the country. The patient mistakenly stopped taking warfarin for 1 month prior to presenting to our center for a routine visit. Luckily, the patient was doing very well without any complication despite the fact that his INR was 1.0.
format Online
Article
Text
id pubmed-6035384
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-60353842018-07-09 Discontinuation of anticoagulant therapy for a month in a patient with HeartMate III continuous-flow left ventricular assist device without thromboembolic events Elasfar, Abdelfatah Jalali, Kafaf Hussein, Mohamed AlHarbi, Ibraheem Amoudi, Osama J Saudi Heart Assoc Case Report The recommended anticoagulation regimen for continuous-flow left ventricular assist device (LVAD) systems is warfarin and aspirin with a targeted international normalized ratio (INR) of 2.0–3.0. Our patient is a 58-year-old male who underwent surgical HeartMate III continuous-flow LVAD implantation 3 months ago outside the country. The patient mistakenly stopped taking warfarin for 1 month prior to presenting to our center for a routine visit. Luckily, the patient was doing very well without any complication despite the fact that his INR was 1.0. Elsevier 2018-07 2018-01-09 /pmc/articles/PMC6035384/ /pubmed/29989026 http://dx.doi.org/10.1016/j.jsha.2017.12.002 Text en © 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Elasfar, Abdelfatah
Jalali, Kafaf
Hussein, Mohamed
AlHarbi, Ibraheem
Amoudi, Osama
Discontinuation of anticoagulant therapy for a month in a patient with HeartMate III continuous-flow left ventricular assist device without thromboembolic events
title Discontinuation of anticoagulant therapy for a month in a patient with HeartMate III continuous-flow left ventricular assist device without thromboembolic events
title_full Discontinuation of anticoagulant therapy for a month in a patient with HeartMate III continuous-flow left ventricular assist device without thromboembolic events
title_fullStr Discontinuation of anticoagulant therapy for a month in a patient with HeartMate III continuous-flow left ventricular assist device without thromboembolic events
title_full_unstemmed Discontinuation of anticoagulant therapy for a month in a patient with HeartMate III continuous-flow left ventricular assist device without thromboembolic events
title_short Discontinuation of anticoagulant therapy for a month in a patient with HeartMate III continuous-flow left ventricular assist device without thromboembolic events
title_sort discontinuation of anticoagulant therapy for a month in a patient with heartmate iii continuous-flow left ventricular assist device without thromboembolic events
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035384/
https://www.ncbi.nlm.nih.gov/pubmed/29989026
http://dx.doi.org/10.1016/j.jsha.2017.12.002
work_keys_str_mv AT elasfarabdelfatah discontinuationofanticoagulanttherapyforamonthinapatientwithheartmateiiicontinuousflowleftventricularassistdevicewithoutthromboembolicevents
AT jalalikafaf discontinuationofanticoagulanttherapyforamonthinapatientwithheartmateiiicontinuousflowleftventricularassistdevicewithoutthromboembolicevents
AT husseinmohamed discontinuationofanticoagulanttherapyforamonthinapatientwithheartmateiiicontinuousflowleftventricularassistdevicewithoutthromboembolicevents
AT alharbiibraheem discontinuationofanticoagulanttherapyforamonthinapatientwithheartmateiiicontinuousflowleftventricularassistdevicewithoutthromboembolicevents
AT amoudiosama discontinuationofanticoagulanttherapyforamonthinapatientwithheartmateiiicontinuousflowleftventricularassistdevicewithoutthromboembolicevents

Ejemplares similares